Established in December 2010, JOINSTAR is a national high-tech enterprise focusing on the research, development, production and sales of in vitro diagnostic(IVD)products. It is the first batch of national "little champion" enterprises specializing in new and special key products, and the hidden champion of Zhejiang Province. It has three major technology platforms, namely, rapid diagnosis, liquid chip and biomedical raw materials. Its product line is widely used in the diagnosis, treatment and prevention of diseases, and chronic disease and health management.
JOINSTAR has established a national science and technology enterprise incubator, a provincial postdoctoral workstation in Zhejiang, a research and development center for IVD enterprises in Zhejiang Province, an advanced research institute for liquid chips, and a centralized supervision platform for the entry and exit of Zhejiang biomedical special items. It has presided over a number of provincial and ministerial level projects, won the second prize of Zhejiang Science and Technology Progress Award, drafted three national industrial standards as the main drafter, won three first sets of equipment in Zhejiang Province and "New Industrial Products in Zhejiang Province", as well as two gold prizes (first prize) of "Zhejiang Manufacturing Boutique", "Zhejiang Second Class Innovative Medical Devices", and "Star of Creation" Cup China Experimental Medicine Annual Excellent Innovative Products.
With the mission of "focusing on medical diagnosis and serving human health", JOINSTAR firmly implements the "i-211" high-quality sustainable development strategy, and firmly grasps the new trend of IVD development of "breaking through neck technology and continuously promoting the new development of underlying technology; excavation of innovative markers and innovative application of markers; continuous breakthrough in R&D and process proprietary technology; expansion of application scenarios", We will continue to make efforts in "platform+transformation" and " Industry, Acdemic, Research and Medical, Application ". With the support of biomedical raw material technology platform, we will strengthen the product portfolio of "liquid chip technology platform+rapid diagnosis technology platform", form the competitive advantage of "multiple indicators+single indicators, immune+molecules" for global application, make due contributions to the main battlefield facing people's life and health, and strive to develop into a company with innovation, benevolence, respect for society and environment, an enterprise that makes employees proud and gains long-term trust from partners.